Therapeutic substituted cyclopentanes

Details for Australian Patent Application No. 2009225706 (hide)

Owner Allergan, Inc.

Inventors Nguyen, Jeremiah H.; Donde, Yariv; Burk, Robert M.

Agent Davies Collison Cave

Pub. Number AU-A-2009225706

PCT Pub. Number WO2009/117388

Priority 61/037,625 18.03.08 US; 12/404,753 16.03.09 US

Filing date 17 March 2009

Wipo publication date 24 September 2009

International Classifications

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61P 17/14 (2006.01) Drugs for dermatological disorders

Event Publications

14 October 2010 PCT application entered the National Phase

  PCT publication WO2009/117388 Priority application(s): WO2009/117388

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225713-Biomarkers and assays for diabetes

2009225693-Therapeutic compounds